Summary
A combined treatment modality incorporating surgery plus BCG immunotherapy was administered to (C57B1/6 × DBA/2)F1 mice grafted with EAkR lymphosarcoma. A single preoperative local or postoperative systemic BCG administration cured 20–30% of the animals, but did not prolong the survival time of these groups. Repeated s.c. injections of BCG resulted in a significant increase in survival time compared to the group submitted to surgery alone.
In contrast, multiple i.v. injections of BCG before and after surgery were no more effective than surgery alone and were less effective than a single postsurgical i.v. injection in producing cures.
We have concluded that for local BCG therapy, multiple injections before and after surgery are more effective than a single injection. However, for systemic therapy, multiple injections are less effective than a single injection applied postoperatively.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Amiel, J. L., Berardet, M.: An experimental model of active immunotherapy preceded by cytoreductive chemotherapy. Europ. J. Cancer 6, 557 (1970).
Baldwin, R. W., Pimm, M. V.: BCG immunotherapy of local subcutaneous growths and postsurgical pulmonary metastases of a transplanted rat epithelioma of spontaneous origin. Int. J. Cancer 12, 420 (1973).
Barilett, G. L., Zbar, B., Rapp, H. S.: Suppression of murine tumor growth by immune reaction to the Bacillus Calmette-Guérin strain of mycobacterium bovis. J. Nat. Cancer Inst. 48, 245 (1975).
Economides, F., Bruley-Rosset, M., Mathé, G.: Effect of pre and post surgical active BCG immunotherapies on murine EAkR lymphosarcoma. Biomedicine 25, 372 (1976).
Economides, F., Bruley-Rosset, M., Mathé, G.: Effects of the removal of the regional lymph nodes on the survival of mice bearing B16 melanoma or EAkR tumour. Biomedicine 25, 390 (1976).
Florentin, I., Huchet, R., Bruley-Rosset, M., Halle-Pannenko, O., Mathé, G.: Studies on the mechanisms of action of BCG. Cancer Immunol. Immunother. 1, 31 (1976).
Goldfarb, P. M., Hardy, M. A.: The immunologic responsiveness of regional lymphocytes in experimental cancer. Cancer 35, 778 (1975).
Halle-Pannenko, O.: Comparison of various preparation of BCG in the experimental screening of the EORTC-ICIG. Cancer Immunol. Immunother. 1, 41 (1976).
Hanna, M. G., Peters, L. C.: Efficacy of intralesional BCG therapy in guinea pigs with disseminated tumor. Cancer 36, 4 (1975).
Khalil, A., Bourut, C., Halle-Pannenko, O., Mathé, G., Rappaport, H.: Histologic reactions of the thymus, spleen, liver and lymph nodes to intravenous and subcutaneous BCG injections. Biomedicine 22, 112 (1975).
Lacour, F., Spira, A., Lacour, J., Prade, M.: Polyadeneic-polyuridylic acid, an adjunct to surgery in the treatment of spontaneous mammary tumors in C3H-H mice and transplantable melanoma in the hamster. Cancer Res. 32, 648 (1972).
Mathé, G.: Immunothérapie active de la leucémie L1210 appliquée après la greffe tumorale. Rev. Franc. Etud. Clin. Biol. 13, 881 (1968).
Mathé, G., Kamel, M., Dezfulian, M., Halle-Pannenko, O., Bourut, C.: An experimental screening for “systemic adjuvants of immunity” applicable in cancer immunotherapy. Cancer Res. 33, 1987 (1973).
Mathé, G., Halle-Pannenko, O., Bourut, C.: Immune manipulation by BCG administered before or after cyclophosphamide for chemo-immunotherapy of L1210 leukaemia. Europ. J. Cancer 10, 661 (1974).
Martin, M., Bourut, C., Halle-Pannenko, O., Mathé, G.: BCG immunotherapy of Lewis tumor residual disease left by local radiotherapy. Biomedicine 23, 337 (1975).
Morton, D. L., Eilber, F. R., Malmigren, R. A., Wood, W. C.: Immunological factors which influence response to immunotherapy in malignant melanoma. Surgery 68, 158 (1970).
Nathanson, L.: Regression of intradermal malignant melanoma after intralesional injection of mycobacterium bovis strain BCG. Cancer Chemoth. Rep. 56, 659 (1972).
Pearson, J. W., Chaparas, S. D., Chirigos, M. A.: Effect of dose and route of Bacillus Calmette-Guérin in chemo-immunostimulation therapy of a murine leukemia. Cancer Res. 33, 1845 (1973).
Pendergrast, W. J., Drake, W. P., Mardiney, M. R.: A proper sequence for the treatment of B16 melanoma chemotherapy, surgery and immunotherapy. J. Nat. Cancer Inst. 57, 539 (1976).
Sparks, F. C., O’Connell, T. X., Lee, Y. T. N.: Adjuvant pre-operative and post-operative immunochemotherapy for mammary adenocarcinoma in rats. Surg. Forum 24, 118 (1973).
Sparks, F. C., Breeding, J. H.: Tumor regression and enhancement resulting from immunotherapy with “Bacillus Calmette-Guérin” and neuraminidase. Cancer Res. 34, 3262 (1974).
Yron, I., Cohen, D., Robinson, E., Harber, M., Weiss, D. W.: Effects of MER and therapeutic irradiation against established isografts and stimulated local recurrence of mammary carcinomas. Cancer Res. 35, 1779 (1975).
Zbar, B., Bernstein, I. D., Rapp, H. J.: Suppression of tumor growth at the site of infection with living Bacillus Calmette-Guérin. J. Nat. Cancer Inst. 46, 831 (1971).
Zatz, M. M.: Effects of BCG on lymphocyte trapping. J. of Immunol. 116, 1587 (1976).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1977 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Economides, F., Bruley-Rosset, M., Mathé, G. (1977). Treatment of Murine EAkR Lymphosarcoma by Surgery Combined With Systemic or Local Active BCG Immunotherapy Applied Repeatedly. In: Mathé, G. (eds) Tactics and Strategy in Cancer Treatment. Recent Results in Cancer Research / Fortschritte der Krebsforschung / Progrès dans les recherches sur le cancer, vol 62. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81174-6_9
Download citation
DOI: https://doi.org/10.1007/978-3-642-81174-6_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-81176-0
Online ISBN: 978-3-642-81174-6
eBook Packages: Springer Book Archive